Sudarshan Pharma Industries Profit & Loss Annual

BSE: 543828 | NSE: - | ISIN: INE00TV01023 | Sector: Biotechnology & Drugs

36.25 0.00 (0.00%)Updated : 16 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	655.53	470.17	441.97	447.31
Other Net	8.71	0.85	1.53	-0.05
Diluted Weighted Average Shares	24.02	24.21	24.07	12.85
Depreciation/ Amortization	3.79	2.22	1.24	0.91
Operating Income	47.53	34.88	21.57	14.02
Net Income	23.30	15.95	11.46	7.04
Income Availableto Com Excl Extra Ord	23.30	15.95	11.46	7.04
Other Operating Expenses Total	24.93	20.48	0.00	0.00
Net Income Before Taxes	30.54	21.63	15.23	9.50
Minority Interest	-0.07	-	-	-
Net Income After Taxes	23.37	15.95	11.46	7.04
Income Availableto Com Incl Extra Ord	23.30	15.95	11.46	7.04
Costof Revenue Total	619.38	439.76	422.48	430.95
Gross Profit	83.68	65.29	41.06	30.38
Interest Inc( Exp) Net- Non- Op Total	-25.70	-14.10	-7.87	-4.24
Unusual Expense( Income)	0.00	2.82	-	-
Diluted Net Income	23.30	15.95	11.46	7.04
Provisionfor Income Taxes	7.17	5.68	3.77	2.46
period Type	-	-	-	-
Net Income Before Extra Items	23.30	15.95	11.46	7.04
Total Revenue	703.06	505.05	463.54	461.33
period Length	12.00	12.00	12.00	12.00
Revenue	703.06	505.05	463.54	461.33
Selling/ General/ Admin Expenses Total	7.44	4.89	18.25	15.46
Diluted Normalized EPS	0.97	0.78	0.48	0.56
Diluted EPS Excluding Extra Ord Items	0.97	0.66	0.48	0.55
Gain( Loss)on Saleof Assets	-	-	0.00	-0.24
DPS- Common Stock Primary Issue	-	-	-	0.03

*All figures in crores except per share values

Trending Stocks

1,035.00+40.00(4.02%)

2,079.30+29.30(1.43%)

1,246.00+17.00(1.38%)

11,400.00-549.00 (-4.59%)

2,851.05-96.35 (-3.27%)

Related News